Citation

Shouksmith AE, Gawel JM, Nawar N, Sina D, Raouf YS, Bukhari S, He L, Johns AE, Manaswiyoungkul P, Olaoye OO, Cabral AD, Sedighi A, de Araujo ED, Gunning PT.: Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia. ACS Med Chem Lett, Volume 11 (1), 2020

Authors

Bukhari S, Cabral AD, de Araujo ED, Gawel JM, Gunning PT., He L, Johns AE, Manaswiyoungkul P, Nawar N, Olaoye OO, Raouf YS, Sedighi A, Shouksmith AE, Sina D

Journal

ACS Med Chem Lett

Year

2020

DOI

10.1021/acsmedchemlett.9b00471

PubMed

31938464

Machine-readable

REST APIRDF